Abstract
The primary objective is to identify and describe the complications associated with the use of intravenous lipid emulsion (ILE) therapy as an antidote for lipophilic drug toxicity. This study is a retrospective chart review of patients treated with ILE at two academic medical centers between 2005 and 2012. Based on previously reported complications, we hypothesized that pancreatitis, ARDS, and lipemia-induced laboratory interference might occur. Clinical definitions of these complications were defined a priori. Subjects treated with ILE who did not develop at least one complication were excluded. A total of nine patients were treated with ILE during the study period, six of whom experienced potential complications as a result of the ILE. Two patients developed pancreatitis, and four patients had lipemia-induced interference of interpretation of laboratory studies, despite ultracentrifugation. Laboratory interference precluded one patient from being an organ donor. Three patients developed ARDS; although temporally associated, a causal relationship between ILE and the development of ARDS cannot be clearly established. As ILE is increasingly used for less severe cases of drug toxicity, clinicians should be aware of potential complications associated with its use. A risk–benefit assessment for the use of ILE should be implemented on a case-by-case basis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Centers for Disease Control and Prevention (CDC) (2011) Drug overdose deaths: Florida, 2003–2009. MMWR Morb Mortal Wkly Rep 60:869–872
Centers for Disease Control and Prevention, National Center for Injury Prevention and Control. Unintentional poisoning data and statistics. http://www.cdc.gov/HomeandRecreationalSafety/Poisoning/data.html. Accessed 29 July, 2012.
Bronstein AC, Spyker DA, Cantilena LR Jr et al (2011) 2010 Annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 28th Annual report. Clin Toxicol 49:910–941
Geib AJ, Leibelt E, Manini AF (2012) On behalf of the toxicology investigators’ consortium (ToxIC). Clinical experience with intravenous lipid emulsion for drug-induced cardiovascular collapse. J Med Toxicol 8:10–14
Rothschild L, Bern S, Oswald S et al (2010) Intravenous lipid emulsion in clinical toxicology. Scand J Trauma Resus Emerg Med 18:51
Jamaty C, Bailey B, Larocque A et al (2010) Lipid emulsions in the treatment of acute poisoning: a systematic review of human and animal studies. Clin Toxicol 48:1–27
French D, Armenian P, Ruan W et al (2011) Serum verapamil concentrations before and after Intralipid® therapy during treatment of an overdose. Clin Toxicol (Phila) 49:340–344
Levine M, Brooks DE, Truitt CA et al (2011) Toxicology in the ICU: Part 1: general overview and approach to treatment. Chest 140:795–806
American College of Medical Toxicology (2011) ACMT position statement: interim guidance for the use of lipid resuscitation therapy. J Med Toxicol 7:81–82
Tactachi F, Sanaei-Zadeh H, Sepehrian B et al (2012) Lipid emulsion improves Glasgow coma scale and decreases blood glucose level in the setting of acute non-local anesthetic drug poisoning—a randomized controlled trial. Eur Rev Med Pharmacol Sci 16(Suppl 1):38–42
Finn SD, Uncles DR, Willers J et al (2009) Early treatment of a quetiapine and sertraline overdose with Intralipid. Anesthesia 64:191–194
Grunbaum AM, Gilfix BM, Gosselin S et al (2012) Analytical interferences resulting from intravenous lipid emulsion. Clin Toxicol (Phila) 50:812–817
Levine M, Brooks DE, Franken A et al (2012) Delayed-onset seizure and cardiac arrest after amitriptyline overdose, treated with intravenous lipid emulsion therapy. Pediatrics 130:e432–e438
Turner-Lawrence DE, Kearns W II (2008) Intravenous fat emulsion; a potential novel antidote. J Med Toxicol 4:109–114
Lekka ME, Liokatis S, Nathanali C et al (2004) The impact of intravenous fat emulsion administration in acute lung injury. Am J Respir Crit Care Med 169:638–644
Ewald N, Hardt PD, Kloer HU (2009) Severe hypertriglyceridemia and pancreatitis: presentation and management. Curr Opin Lipidol 206:497–504
Gan SI, Edwards AL, Symonds CJ et al (2006) Hypertriglyceridemia-induced pancreatitis: a case-based review. World J Gastroenterol 12:197–202
Tsuang W, Navaneethan U, Ruis L et al (2009) Hypertriglyceridemic pancreatitis: presentation and management. Am J Gastroenterol 104:984–991
Hackert T, Hartwig W, Fritz S et al (2009) Ischemic acute pancreatitis: clinical features of 11 patients and review of the literature. Am J Surg 197:450–454
Hubl W, Wejbora R, Shafti-Keramat I (1994) Enzymatic determination of sodium, potassium, and chloride in abnormal (hemolyzed, icteric, lipemic, paraproteinemic, or uremic) serum samples compared with indirect determination with ion-selective electrodes. Clin Chem 40:1528–1531
Funding/Disclosure
This study was non-funded. There are no financial, litigational, or other conflicts of interest to disclose.
Author information
Authors and Affiliations
Corresponding author
Additional information
The work was done in Banner Good Samaritan Medical Center and University of Pittsburgh.
Rights and permissions
About this article
Cite this article
Levine, M., Skolnik, A.B., Ruha, AM. et al. Complications Following Antidotal Use of Intravenous Lipid Emulsion Therapy. J. Med. Toxicol. 10, 10–14 (2014). https://doi.org/10.1007/s13181-013-0356-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13181-013-0356-1